Innoviva (INVA) Cash from Investing Activities (QoQ) (2010 - 2025)
Innoviva (INVA) Cash from Investing Activities (QoQ) (2010 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Innoviva |
1.65 Bn |
1.05 Bn |
75.83 Mn |
| Date | Value |
|---|
| Sep 30, 2025 |
-49.10% |
| Jun 30, 2025 |
195.52% |
| Sep 30, 2022 |
-1,801.51% |
| Jun 30, 2022 |
98.24% |
| Sep 30, 2021 |
-29.32% |
| Jun 30, 2021 |
441.07% |
| Mar 31, 2021 |
91.63% |
| Dec 31, 2020 |
-3,611.54% |
| Sep 30, 2020 |
-21.43% |
| Jun 30, 2020 |
-143.63% |
| Mar 31, 2020 |
-69.14% |
| Dec 31, 2019 |
426.25% |
| Sep 30, 2019 |
-179.26% |
| Jun 30, 2019 |
127.11% |
| Mar 31, 2019 |
-62.67% |
| Dec 31, 2018 |
-437.18% |
| Sep 30, 2018 |
48.95% |
| Jun 30, 2018 |
-65.76% |
| Mar 31, 2018 |
202.45% |
| Dec 31, 2017 |
-18.86% |
